Dr. King and Dr. Laurencin of Connecticut Institute for Clinical and Translational Science and the University of Connecticut opened the Food and Drug Administration (FDA) Commissioner Health Disparities Lectureship and gave a talk to employees addressing ways to consider race, culture and ethnicity in regulatory actions. The FDA Commissioner Health Disparities Lectureship is the first lectureship of its kind.

We are able to continue our activities, explore critical research areas, and implement new programs through the generous support of individuals, corporations, and foundations. We are dedicated to our mission and remain inspired not only by those who live with diabetes, but those who have made diabetes their cause. If you are interested in supporting our efforts to promote Asian American health, please click here.